|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Zentalis Pharmaceuticals, Llc (ZNTL) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
84,924,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$ - $ |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Zentalis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. Co. is developing a pipeline of product candidates with an initial focus on validated oncology targets. Co. has two primary product candidates: ZN-c3, an inhibitor of Wee1, a protein tyrosine kinase, and ZN-c5, an oral selective estrogen receptor degrader. Co.'s other clinical product candidates include ZN-d5, a selective inhibitor of B-cell lymphoma 2 and ZN-e4, an irreversible inhibitor of mutant epidermal growth factor receptor.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
22,000 |
22,000 |
Total Buy Value |
$0 |
$0 |
$219,391 |
$219,391 |
Total People Bought |
0 |
0 |
2 |
2 |
Total Buy Transactions |
0 |
0 |
2 |
2 |
Total Shares Sold |
12,953 |
41,815 |
68,993 |
346,626 |
Total Sell Value |
$157,325 |
$490,017 |
$1,047,834 |
$8,137,870 |
Total People Sold |
2 |
5 |
8 |
8 |
Total Sell Transactions |
2 |
8 |
12 |
35 |
End Date |
2024-04-07 |
2024-01-05 |
2023-07-07 |
2022-07-07 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Sun Anthony Y |
President & CEO |
|
2022-02-02 |
4 |
AS |
$57.87 |
$606,966 |
D/D |
(10,471) |
1,171,775 |
|
- |
|
Sun Anthony Y |
President & CEO |
|
2022-02-01 |
4 |
AS |
$56.81 |
$602,926 |
D/D |
(10,471) |
1,182,246 |
|
- |
|
Voliotis Dimitris |
SVP, Clinical Development |
|
2022-01-20 |
4 |
AS |
$60.52 |
$606,323 |
D/D |
(10,000) |
6,250 |
|
- |
|
Voliotis Dimitris |
SVP, Clinical Development |
|
2022-01-20 |
4 |
OE |
$18.00 |
$180,000 |
D/D |
10,000 |
16,250 |
|
- |
|
Bunker Kevin D. |
Chief Operating Officer |
|
2022-01-20 |
4 |
AS |
$59.17 |
$599,912 |
I/I |
(10,000) |
180,000 |
|
- |
|
Voliotis Dimitris |
SVP, Clinical Development |
|
2022-01-19 |
4 |
AS |
$60.55 |
$607,931 |
D/D |
(10,000) |
6,250 |
|
- |
|
Voliotis Dimitris |
SVP, Clinical Development |
|
2022-01-19 |
4 |
OE |
$18.00 |
$180,000 |
D/D |
10,000 |
16,250 |
|
- |
|
Voliotis Dimitris |
SVP, Clinical Development |
|
2022-01-18 |
4 |
AS |
$61.70 |
$626,491 |
D/D |
(10,000) |
6,250 |
|
- |
|
Voliotis Dimitris |
SVP, Clinical Development |
|
2022-01-18 |
4 |
OE |
$18.00 |
$180,000 |
D/D |
10,000 |
16,250 |
|
- |
|
Gallagher Cam |
Director |
|
2022-01-18 |
4 |
AS |
$61.71 |
$626,376 |
D/D |
(10,000) |
397,203 |
|
- |
|
Bunker Kevin D. |
Chief Operating Officer |
|
2022-01-10 |
4 |
AS |
$67.24 |
$684,097 |
I/I |
(10,000) |
190,000 |
|
- |
|
Gallagher Cam |
Director |
|
2022-01-05 |
4 |
AS |
$73.18 |
$754,861 |
D/D |
(10,000) |
407,203 |
|
- |
|
Sun Anthony Y |
President & CEO |
|
2022-01-04 |
4 |
AS |
$77.71 |
$823,870 |
D/D |
(10,471) |
1,192,717 |
|
- |
|
Blackwell Kimberly |
Director |
|
2022-01-03 |
4 |
AS |
$83.74 |
$83,740 |
D/D |
(1,000) |
5,000 |
|
- |
|
Blackwell Kimberly |
Director |
|
2022-01-03 |
4 |
OE |
$47.80 |
$47,800 |
D/D |
1,000 |
6,000 |
|
- |
|
Sun Anthony Y |
President & CEO |
|
2022-01-03 |
4 |
AS |
$78.26 |
$838,438 |
D/D |
(10,471) |
1,203,188 |
|
- |
|
Bunker Kevin D. |
Chief Operating Officer |
|
2021-12-30 |
4 |
GD |
$0.00 |
$0 |
D/D |
8,750 |
746,317 |
|
- |
|
Bunker Kevin D. |
Chief Operating Officer |
|
2021-12-20 |
4 |
AS |
$77.45 |
$792,431 |
I/I |
(10,000) |
200,000 |
|
- |
|
Sun Anthony Y |
President & CEO |
|
2021-12-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
15,000 |
1,213,659 |
|
- |
|
Gallagher Cam |
Director |
|
2021-12-15 |
4 |
AS |
$71.28 |
$740,337 |
D/D |
(10,000) |
417,203 |
|
- |
|
Bunker Kevin D. |
Chief Operating Officer |
|
2021-12-10 |
4 |
AS |
$70.29 |
$717,106 |
I/I |
(10,000) |
210,000 |
|
- |
|
Gallagher Cam |
Director |
|
2021-12-06 |
4 |
AS |
$71.33 |
$713,300 |
D/D |
(10,000) |
427,203 |
|
- |
|
Sun Anthony Y |
President & CEO |
|
2021-11-26 |
4/A |
GD |
$0.00 |
$0 |
I/I |
125,000 |
103,650 |
|
- |
|
Gallagher Cam |
Director |
|
2021-11-15 |
4 |
AS |
$75.02 |
$753,619 |
D/D |
(10,000) |
437,203 |
|
- |
|
Bunker Kevin D. |
Chief Operating Officer |
|
2021-11-10 |
4 |
AS |
$78.15 |
$781,471 |
I/I |
(10,000) |
230,000 |
|
- |
|
243 Records found
|
|
Page 5 of 10 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|